Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 50 results in range #29,101 to #29,150.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Lucatumumab (2 revisions)
  2. Lugol's iodine (2 revisions)
  3. Luliconazole clinical pharmacology (2 revisions)
  4. Luliconazole clinical studies (2 revisions)
  5. Luliconazole contraindications (2 revisions)
  6. Luliconazole indications and usage (2 revisions)
  7. Luliconazole microbiology (2 revisions)
  8. Lumbar arteries (2 revisions)
  9. Lumbar hernia (2 revisions)
  10. Lumbar nerves (2 revisions)
  11. Lumbar plexus (2 revisions)
  12. Lung (2 revisions)
  13. Lung buds (2 revisions)
  14. Lung cancer echocardiography or ultrasound (2 revisions)
  15. Lung cancer x ray (2 revisions)
  16. Lung mass diagnostic study of choice (2 revisions)
  17. Lung mass echocardiography and ultrasound (2 revisions)
  18. Lung mass mass differential diagnosis (2 revisions)
  19. Lung mass natural history, complications and prognosis (2 revisions)
  20. Lung mass risk factors (2 revisions)
  21. Lung volumes (2 revisions)
  22. Lupus anticoagulant (2 revisions)
  23. Lupus nephritis case study one (2 revisions)
  24. Lupus vasculitis (2 revisions)
  25. Lurtotecan (2 revisions)
  26. Lutembacher's syndrome X-Ray (2 revisions)
  27. Lutembacher's syndrome case study one (2 revisions)
  28. Lutz-Richner and Landolt syndrome (2 revisions)
  29. Ly6/plaur domain containing 5 (2 revisions)
  30. Lycoperdonosis (2 revisions)
  31. Lyme resident survival guide (2 revisions)
  32. Lymecycline (2 revisions)
  33. Lymph capillaries (2 revisions)
  34. Lymph node (2 revisions)
  35. Lymph vascular system (2 revisions)
  36. Lymph vessel (2 revisions)
  37. Lymphadenectomy (2 revisions)
  38. Lymphadenopathy chest x ray (2 revisions)
  39. Lymphadenopathy classification scheme (2 revisions)
  40. Lymphangioma chest x ray (2 revisions)
  41. Lymphangioma circumscriptum (2 revisions)
  42. Lymphangioma screening (2 revisions)
  43. Lymphangiomyomatosis case study one (2 revisions)
  44. Lymphangiomyomatosis cost-effectiveness of therapy (2 revisions)
  45. Lymphangiomyomatosis primary prevention (2 revisions)
  46. Lymphangiomyomatosis secondary prevention (2 revisions)
  47. Lymphangiosarcoma case study one (2 revisions)
  48. Lymphangiosarcoma electrocardiogram (2 revisions)
  49. Lymphangiosarcoma primary prevention (2 revisions)
  50. Lymphangiosarcoma screening (2 revisions)

View ( | ) (20 | 50 | 100 | 250 | 500)